Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.

Gjertsson I, Laurie KL, Devitt J, Howe SJ, Thrasher AJ, Holmdahl R, Gustafsson K.

Mol Ther. 2009 Apr;17(4):632-40. doi: 10.1038/mt.2009.299. Epub 2009 Jan 27.

2.

Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis.

Eneljung T, Tengvall S, Jirholt P, Henningsson L, Holmdahl R, Gustafsson K, Gjertsson I.

Clin Dev Immunol. 2013;2013:345092. doi: 10.1155/2013/345092. Epub 2013 Nov 26.

3.

Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.

Bäcklund J, Nandakumar KS, Bockermann R, Mori L, Holmdahl R.

J Immunol. 2003 Oct 1;171(7):3493-9.

4.

Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.

Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.

Clin Immunol. 2007 Jan;122(1):75-84. Epub 2006 Oct 11.

PMID:
17045846
5.

Mice producing less reactive oxygen species are relatively resistant to collagen glycopeptide vaccination against arthritis.

Batsalova T, Dzhambazov B, Klaczkowska D, Holmdahl R.

J Immunol. 2010 Sep 1;185(5):2701-9. doi: 10.4049/jimmunol.1000385. Epub 2010 Aug 4.

6.

Comparative analysis of collagen type II-specific immune responses during development of collagen-induced arthritis in two B10 mouse strains.

Batsalova T, Lindh I, Bäcklund J, Dzhambazov B, Holmdahl R.

Arthritis Res Ther. 2012 Nov 1;14(6):R237. doi: 10.1186/ar4080.

7.

Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.

Bäcklund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, Kihlberg J, Holmdahl R.

Eur J Immunol. 2002 Dec;32(12):3776-84.

8.

Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.

Jaen O, Rullé S, Bessis N, Zago A, Boissier MC, Falgarone G.

Immunology. 2009 Jan;126(1):35-44. doi: 10.1111/j.1365-2567.2008.02875.x. Epub 2008 Aug 27.

9.

Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis.

Tengvall S, Eneljung T, Jirholt P, Turesson O, Wing K, Holmdahl R, Kihlberg J, Stern A, Mårtensson IL, Henningsson L, Gustafsson K, Gjertsson I.

PLoS One. 2016 May 9;11(5):e0154630. doi: 10.1371/journal.pone.0154630. eCollection 2016.

10.

Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.

Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, Jung YO, Koh HJ, Do JH, Kim H, Kim HY.

Arthritis Res Ther. 2004;6(3):R213-9. Epub 2004 Mar 11.

11.

Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.

Mukherjee P, Yang SY, Wu B, Song Z, Myers LK, Robbins PD, Wooley PH.

Ann Rheum Dis. 2005 Nov;64(11):1550-6. Epub 2005 Apr 28.

12.
13.

The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.

Kjellén P, Brunsberg U, Broddefalk J, Hansen B, Vestberg M, Ivarsson I, Engström A, Svejgaard A, Kihlberg J, Fugger L, Holmdahl R.

Eur J Immunol. 1998 Feb;28(2):755-67.

14.

Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.

Svendsen P, Andersen CB, Willcox N, Coyle AJ, Holmdahl R, Kamradt T, Fugger L.

J Immunol. 2004 Dec 1;173(11):7037-45.

15.

T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice.

von Delwig A, Altmann DM, Charlton FG, McKie N, Isaacs JD, Holmdahl R, Robinson JH.

Ann Rheum Dis. 2007 May;66(5):599-604. Epub 2006 Nov 17.

16.

Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis.

Batsalova T, Dzhambazov B, Merky P, Bäcklund A, Bäcklund J.

Arthritis Rheum. 2010 Jul;62(7):1911-20. doi: 10.1002/art.27460.

17.

Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.

Merky P, Batsalova T, Bockermann R, Dzhambazov B, Sehnert B, Burkhardt H, Bäcklund J.

Arthritis Res Ther. 2010;12(4):R155. doi: 10.1186/ar3108. Epub 2010 Aug 3.

18.

Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis.

Park KS, Park MJ, Cho ML, Kwok SK, Ju JH, Ko HJ, Park SH, Kim HY.

Mod Rheumatol. 2009;19(6):581-9. doi: 10.1007/s10165-009-0210-0. Epub 2009 Aug 21. Review.

PMID:
19697097
20.

Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers.

Huang JC, Vestberg M, Minguela A, Holmdahl R, Ward ES.

Int Immunol. 2004 Feb;16(2):283-93.

PMID:
14734614

Supplemental Content

Support Center